Christopher G. Rowan
Christopher G. Rowan publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Toxicology, on topics such as Potassium and Related Disorders, Pharmacovigilance and Adverse Drug Reactions and Heart Failure Treatment and Management.
- World rank
- #2,651,391 of 7,710,434 ranked researchers
- Rank in United States
- #775,322 of 1,627,098
- Works
- 52
- Citations
- 936
- Citations per work
- 18.0
What does Christopher G. Rowan research?
Christopher G. Rowan's work is mostly in Medicine (30%), Pharmacology, Toxicology and Pharmaceutics (5%), Mathematics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else3160.3%
- Health Sciences1630.2%
- Medicine1630.2%
- Life Sciences35.1%
- Physical Sciences24.4%
- Mathematics24.4%
- 1Pulmonary and Respiratory Medicine14% of their works
- 2Cardiology and Cardiovascular Medicine7% of their works
- 3Toxicology5% of their works
- 4Hematology4% of their works
- 5Rheumatology4% of their works
- 6Statistics and Probability4% of their works
Research topics
- Potassium and Related Disorders
- Pharmacovigilance and Adverse Drug Reactions
- Heart Failure Treatment and Management
- Membrane-based Ion Separation Techniques
- Pharmaceutical Practices and Patient Outcomes
- Psoriasis: Treatment and Pathogenesis
- Advanced Causal Inference Techniques
- Medication Adherence and Compliance
Which keywords describe Christopher G. Rowan's research?
The keywords of their largest research topics: Heart Failure, Hyperkalemia, Renin-Angiotensin-Aldosterone System Inhibitors, Adverse Drug Reactions, Diagnosis, Guidelines, Pharmacovigilance and Capacitive Deionization.
- Medication Adherence
- Propensity Score
- Causal Inference
- Polypharmacy
- Capacitive Deionization
- Guidelines
- Adverse Drug Reactions
- Hyperkalemia
- Heart Failure
- Renin-Angiotensin-Aldosterone System Inhibitors
- Diagnosis
- Pharmacovigilance
- Inappropriate Medication Use
- Water Desalination
- IL-17
- TH17 Cells
- Treatment Adherence
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Heart Failure212 topics
- Hyperkalemia151 topic
- Renin-Angiotensin-Aldosterone System Inhibitors151 topic
- Adverse Drug Reactions61 topic
- Diagnosis61 topic
- Guidelines61 topic
- Pharmacovigilance61 topic
- Capacitive Deionization51 topic
- Inappropriate Medication Use51 topic
- Polypharmacy51 topic
- Water Desalination51 topic
- Causal Inference41 topic
- IL-1741 topic
- Propensity Score41 topic
- TH17 Cells41 topic
- Medication Adherence31 topic
- Treatment Adherence31 topic
Where does Christopher G. Rowan work?
Christopher G. Rowan's main affiliation in the publication record is Vifor Pharma (United States), United States.
How many publications and citations does Christopher G. Rowan have?
OpenAlex counts 52 works and 936 citations for Christopher G. Rowan, an h-index of 16, ranking #2,651,391 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Christopher G. Rowan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.